Pointerra (ASX:3DP) share price rockets 12% on 'record quarterly cash receipts'

Pointerra comes in with a solid Q2 FY22 today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Man puts thumb up next to stock market graph

Image source: Getty Images

Key points

  • Pointerra released its December 2021 quarter (Q2 FY22) activities and cash flow report today.
  • In the report it outlined record quarterly cash receipts from customers.
  • All other areas saw growth and new customers added as well.
  • Pointerra share price is up 12% on the day.

Shares in 3D geospatial data company Pointerra Ltd (ASX: 3DP) are rocketing today and now trade 12% higher at 40 cents apiece.

Investors are piling into Pointerra during Wednesday's session following the release of its December 2021 quarter (Q2 FY22) activities and cash flow report. Let's take a closer look.

Pointerra share price jumps solid cash flow results

The company outlined several investment highlights it had achieved last quarter, including:

  • Record quarterly cash receipts from customers $2.85 million
  • Cash flow positive quarter from operations $800,000
  • Energy Utilities Sector – material contracts awarded (between $4.33 and $6.6 million) and existing customers grow Actual Cash Value (ACV) spend
  • AEC Sector – new customers added and existing customers grow ACV spend
  • Survey & Mapping Sector – new customers added and existing customers grow ACV spend
  • Transport Sector – new customers added and existing customers grow ACV spend
  • Mining, Oil & Gas Sector – new customers added and existing customers grow ACV spend

What happened last quarter for Pointerra?

The quarter was highlighted by record cash receipts from customers to $2.85 million and cash flow from operations.

It also outlined several contract wins totalling between $4.33 million and $6.60 million, in the "strategically important US energy utilities sector" that was announced last year.

Coupled with these material contract awards, growth in spend by existing customers during the quarter generated further uplift in Pointerra's USD Actual Cash Value (ACV) run rate (ACV is akin to annual recurring revenue only for subscription services).

The company says it "looks forward to updating the market with a revised US$ ACV run rate, with the next update being provided by 31 January 2022 at the latest".

Pointerra says that a number of new customers were added during the quarter in its Survey and Mapping segment as well. Australian growth for instance is increasingly being driven by "state and local government agency mandates that survey & mapping firms deliver data via Pointerra3D Core".

Meanwhile, in the US, inside sales initiatives continued during the quarter which resulted in a "very large number of lower dollar ACV prospects".

Aside from that, the company realised a period of growth in all of its core operating segments, earmarked by the continued adoption of its "solution" by Australian road and rail operators.

During the quarter, payments for Research and Development (R&D) of $355,000 were made as salary allocations to team members who are "100% focused on R&D activities".

Pointerra notes that cash outflows for the quarter were 'in line with expectations' and that the balance sheet showed around $5 million in cash as of 31 December 2021.

What's next for Pointerra?

The company remains prioritised on R&D efforts to build out its strategic areas. Some of these include a platform to underpin the delivery of point cloud analytics to Pointerra3D Core customers and developing a catalogue of analytics algorithms for Pointerra3D Analytics customers.

Aside from that, Pointerra is focused on broadening the platform to support complementary data types and exploring methods to apply neural network machine learning.

The company didn't provide any specific revenue or profit guidance. The Pointerra share price is up 12% on the day and has rallied more than 8% in the past week of trading.

The author has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Pointerra Limited. The Motley Fool Australia has recommended Pointerra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »